Clinical Trial: A Study to Evaluate the Safety and Tolerability of Eravacycline in Children Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)

U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06794541) titled 'A Study to Evaluate the Safety and Tolerability of Eravacycline in Children Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)' on Jan. 15.

Brief Summary: A Phase 2 trial to assess safety, tolerability, and pharmacokinetics of eravacycline in children aged 8 to <18 years with cIAI.

Study Start Date: Jan. 31

Study Type: INTERVENTIONAL

Condition: Complicated Intra-abdominal Infections (cIAI)

Intervention: DRUG: Eravacycline 2mg/kg

intravenous (IV) infusion

DRUG: Eravacycline 1.5mg/kg

intravenous (IV) infusion

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Innoviva Specialty Therapeutics

Disclaimer: Curated by...